Santhera Pharmaceuticals Holding AG (SWX:SANN)
Switzerland
· Delayed Price · Currency is CHF
15.90
+0.60 (3.92%)
Mar 9, 2026, 5:31 PM CET
SWX:SANN Ratios and Metrics
Market cap in millions CHF. Fiscal year is January - December.
Millions CHF. Fiscal year is Jan - Dec.
| Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Mar '26 Mar 9, 2026 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Market Capitalization | 213 | 167 | 90 | 75 | 56 | 54 | |
| Market Cap Growth | 1.91% | 85.24% | 19.92% | 34.92% | 3.51% | -57.20% | |
| Enterprise Value | 236 | 177 | 130 | 103 | 91 | 96 | |
| Last Close Price | 15.30 | 13.82 | 9.81 | 13.80 | 13.30 | 28.00 | |
| PE Ratio | - | - | 1.65 | - | - | - | |
| PS Ratio | 4.35 | 4.28 | 0.87 | 10.08 | -35.00 | 3.59 | |
| PB Ratio | -83.14 | 6.04 | 1.51 | -1.72 | 42.04 | -8.49 | |
| P/FCF Ratio | - | - | 1.91 | - | - | - | |
| P/OCF Ratio | - | - | 1.91 | - | - | - | |
| EV/Sales Ratio | 4.81 | 4.53 | 1.26 | 13.82 | - | 6.41 | |
| EV/EBITDA Ratio | - | - | 2.42 | - | - | - | |
| EV/EBIT Ratio | - | - | 2.54 | - | - | - | |
| EV/FCF Ratio | -5.74 | - | 2.76 | - | - | - | |
| Debt / Equity Ratio | -16.08 | 1.47 | 0.36 | -1.02 | 32.36 | -11.20 | |
| Debt / EBITDA Ratio | - | - | 0.40 | - | - | - | |
| Debt / FCF Ratio | - | - | 0.46 | - | - | - | |
| Net Debt / Equity Ratio | -8.91 | -0.01 | -0.15 | -0.99 | 16.39 | -9.25 | |
| Net Debt / EBITDA Ratio | -0.50 | 0.01 | -0.16 | -1.01 | -0.41 | -1.18 | |
| Net Debt / FCF Ratio | -0.56 | 0.01 | -0.19 | -1.44 | -0.58 | -1.35 | |
| Asset Turnover | 0.41 | 0.30 | 1.19 | 0.10 | - | 0.15 | |
| Inventory Turnover | 2.65 | 1.61 | 3.37 | 13.40 | 8.29 | 2.84 | |
| Quick Ratio | 0.51 | 1.19 | 0.71 | 0.05 | 0.71 | 0.58 | |
| Current Ratio | 1.02 | 1.64 | 0.76 | 0.06 | 0.75 | 0.61 | |
| Return on Equity (ROE) | -288.14% | -95.79% | 673.95% | - | - | -908.60% | |
| Return on Assets (ROA) | -26.60% | -15.81% | 36.89% | -36.95% | -39.55% | -32.56% | |
| Return on Invested Capital (ROIC) | -250.98% | -84.45% | 202.40% | -406.92% | -150.70% | -103.78% | |
| Return on Capital Employed (ROCE) | -69.70% | -31.20% | 80.10% | -319.80% | -97.50% | -89.00% | |
| Earnings Yield | -30.76% | -25.09% | 60.65% | -94.37% | -99.47% | -125.46% | |
| FCF Yield | -19.27% | -21.32% | 52.24% | -39.69% | -66.92% | -80.73% | |
| Buyback Yield / Dilution | -9.97% | -4.24% | -79.29% | -78.31% | -156.61% | -21.15% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.